Research - News
In two new studies, a UAB oncologist explores questions of choice and cost in metastatic breast cancer.
This structure will further explain how the virus infects human cells and how progeny viruses are assembled, and it may be a point of attack to disarm the virus.
A UAB study suggests that psychedelic drugs have a positive effect on antisocial, criminal behavior, warranting investigation of psychedelics as a crime reduction therapy.
Overexpression of CCND2 increased growth and division of grafted heart muscle cells, resulting in better heart function and decreased size of dead tissue.
A UAB researcher is investigating antihypertensive drugs in search of those that not only treat high blood pressure, but also boost mobility and independence in older Americans.
These results, seen in animal models, represent a potentially novel therapeutic target for the treatment of seizure disorders.
UAB now has far and away the fastest supercomputer in Alabama, accelerating the volume and speed at which transformational education, research and medical care can occur.
The $2.5 million gift from Medical Properties Trust begins a campaign that will ultimately raise $7.5 million in resources to expand and accelerate the center’s research efforts.
With an economic impact now exceeding $7.15 billion, according to Tripp Umbach, Alabama’s largest single employer’s influence on the state’s economy has grown by more than 50 percent since the last study.
Developers and educators at UAB have developed a solution to meet the challenges of getting educational resources to underserved populations by providing software and hardware programs to better train students in Ethiopia and Zambia.
Four multidisciplinary studies will focus on genetics and associated mechanisms of hyperuricemia gout, an inflammatory arthritis.
Low dietary potassium leads to calcified arteries and aortic stiffness, while increased dietary potassium alleviates those undesirable effects in a mouse model, suggesting dietary potassium may protect against heart disease and death from heart disease in humans.
Chad Thomas Hagwood, Edward E. Partridge, Catherine Danielou, Michelle Cardel and Raymond Thompson were bestowed the awards by the NAS for their personal, academic and professional achievements, service to the community, and philanthropy.
Researchers study the mechanisms that prevent autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis after an infection.
The research supported by the Patient-Centered Outcomes Research Institute will evaluate the effectiveness of different types of exercise programs for people with MS.
The AGHI, a genomics partnership between UAB and HudsonAlpha, is cited for collaboration by Health Connect South.
Virtual reality delivery of CI therapy, a form of physical rehabilitation shown to be highly effective, allows stroke patients to access this complex treatment in their own homes.
UAB and Innovation Depot are among the 42 organizations from 28 states that received more than $17 million to create and expand cluster-focused proof-of-concept and commercialization programs, and early-stage seed capital funds.
This knowledge can provide targets in the search for novel bone-loss therapeutics to treat osteoporosis.
Physics professor Cheng-Chien Chen will use the fellowship to broaden his research in strongly correlated materials, which could lead to scientific advancement in the energy industry.
UAB will be a fundamental player in the Alabama jurisdiction of the program, which has just five awardees, with primary goals of improving scientific research and building workforce capacity.
A new UAB study will investigate the role of autoantibodies and the benefit of therapeutic plasma exchange on a deadly lung disease.
A UAB study suggests a new bone boosting drug is more effective than commonly used bone loss medications in preventing fractures in women with osteoporosis.
UAB’s Civitan Rett Syndrome Clinic has been named a Center of Excellence by rettsyndrome.org, one of the nation’s leading advocacy groups.
A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.
These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.
This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
UAB is joining the All of Us Research Program, an effort led by the National Institutes of Health to drive precision medicine research.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Due to the current opioid crisis, UAB Hospital has launched an Addiction Scholars Program to train health care professionals across the hospital in caring for patients with addiction issues.